Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T20:21:15.035Z Has data issue: false hasContentIssue false

Gabapentin

Published online by Cambridge University Press:  01 June 2018

Philip N. Patsalos  and
Erik K. St Louis
Philip N. Patsalos
Affiliation:
UCL Institute for Neurology
Erik K. St Louis
Affiliation:
Mayo Clinic
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The Epilepsy Prescriber's Guide to Antiepileptic Drugs , pp. 109 - 119
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Suggested Reading

Bergey, GK, Morris, HH, Rosenfeld, W, Blume, WT, Penovich, PE, Morrell, MJ, Leiderman, DB, Crockatt, JG, LaMoreaux, L, Garofalo, E, Pierce, M. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89. Neurology 1997; 49: 739–745.CrossRefGoogle ScholarPubMed
Costa, J, Fareleira, F, Ascenção, R, Borges, M, Sampaio, C, Vaz-Carneiro, A. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia 2011; 52: 1280–1291.CrossRefGoogle ScholarPubMed
Fink, K, Dooley, DJ, Meder, WP, Suman-Chauhan, N, Duffy, S, Clusmann, H, Gothert, M. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002; 42: 229–236.CrossRefGoogle ScholarPubMed
French, J, Glue, P, Friedman, D, Almas, M, Yardi, N, Knapp, L, Pitman, V, Posner, HB. Adjunctive pregabalin vs gabapentin for focal seizures: interpretation of comparative outcomes. Neurology 2016; 87: 1242–1249.CrossRefGoogle ScholarPubMed
French, JA, Kanner, AM, Bautista, J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1252–1260.CrossRefGoogle Scholar
French, JA, Kanner, AM, Bautista, J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004; 62: 1261–1273.CrossRefGoogle Scholar
Fujii, H, Goel, A, Bernard, N, Pistelli, A, Yates, LM, Stephens, S, Han, JY, Matsui, D, Etwell, F, Einarson, TR, Koren, G, Einarson, A. Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study. Neurology 2013; 80: 1565–1570.CrossRefGoogle ScholarPubMed
Gidal, BE, Radulovic, LL, Kruger, S, Rutecki, P, Pitterle, M, Bockbrader, HN. Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Research 2000; 40: 123–127.Google Scholar
Johannessen Landmark, C, Patsalos, PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Reviews in Neurotherapeutics 2010; 10: 119–140.CrossRefGoogle ScholarPubMed
Marson, AG, Kadir, ZA, Hutton, JL, Chadwick, DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997; 38: 859–880.Google Scholar
McLean, MJ, Gidal, BE. Gabapentin dosing in the treatment of epilepsy. Clinical Therapeutics 2003; 25: 1382–1406.CrossRefGoogle ScholarPubMed
Ohman, I, Vitolis, S, Tomson, T. Pharmacokinetics of gabapentin during delivery, in the neonatal period and lactation. Epilepsia 2005; 46: 1621–1624.CrossRefGoogle ScholarPubMed
Patsalos, PN. Antiepileptic drug interactions: a clinical guide, 3rd edition. Springer, London, UK; 2016.CrossRefGoogle Scholar
Patsalos, PN, Zugman, M, Lake, C, James, A, Ratnaraj, N, Sander, JW. Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: a comparison of free non-protein-bound concentrations. Epilepsia 2017; 58: 1234–1243.CrossRefGoogle Scholar
St. Louis, EK. The art of managing conversions between antiepileptic drugs; maximizing patient tolerability and quality of life. Pharmaceuticals 2010; 3: 2956–2969.Google Scholar
St. Louis, EK, Gidal, BE, Henry, TR, Kaydanova, Y, Krumholz, A, McCabe, PH, Montouris, GD, Rosenfeld, WE, Smith, BJ, Stern, JM, Waterhouse, EJ, Schulz, RM, Garnett, WR, Bramley, T. Conversions between monotherapies in epilepsy: expert consensus. Epilepsy and Behavior 2007; 11: 222–234.CrossRefGoogle ScholarPubMed
Vollmer, KO, von Hodenberg, A, Kolle, EU. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittel Forschung Drug Research 1988; 36: 830–839.Google Scholar
Wolf, SM, Shinner, S, Kang, H, Gil, KB, Moshe, SL. Gabapentin toxicity in children manifesting as behavioural changes. Epilepsia 1995; 36: 1203–1205.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×